Results 101 to 110 of about 1,736,765 (225)
Endocrinology, Diabetes &Metabolism, Volume 9, Issue 5, September 2026.Tirzepatide and SGLT2 inhibitors act through distinct but complementary mechanisms in obesity‐related HFpEF: tirzepatide targets adiposity, inflammation, and insulin resistance, while SGLT2 inhibitors improve decongestion, myocardial energetics, and cardiac remodeling.
Zakariye Isak Mohamed +8 more
wiley +1 more source
Reversible Cardio‐Renal‐Cerebral Syndrome in a Dog: A Case Report
Journal of Veterinary Internal MedicineA 14‐year‐old miniature Pinscher was presented with azotemia, severe hyperkalemia, and oliguria caused by decompensation of chronic renal disease, along with bradycardia resulting from third‐degree atrioventricular (AV) block.
Gianira Candelario +5 more
doaj +1 more source
Endocrinology, Diabetes &Metabolism, Volume 9, Issue 5, September 2026.DPP‐4 Inhibitors associated withheart failure events in patients with type‐2 diabetes. This study found statistically insignificant summary effect for all DPP‐4 inhibitors combined but found asignificant association of saxagliptin with heart failure events (RR = 1.24, 95% CI 1.05–1.47). Results are to be interpreted with caution.
Shishir Nepal, Shiva Prasad Nepal
wiley +1 more source
Food Science &Nutrition, Volume 14, Issue 9, September 2026.Higher Dietary Inflammatory Index scores were associated with greater odds of cardiorenal anemia syndrome in NHANES and of a related phenotype in KNHANES. Exploratory mediation analyses showed positive indirect associations through six systemic inflammatory indices.
Shirong Lin +9 more
wiley +1 more source
Role of Iron Deficiency and Anemia in Cardio-Renal Syndromes
, 2012 Chronic heart failure is a common disorder associated with unacceptably high mortality rates. Chronic renal disease and anemia are two important comorbidities that significantly influence morbidity and mortality in patients with chronic heart failure ...
Attanasio P +4 more
core +2 more sources
Кардиоваскулярная терапия и профилактика, 1970 Aim. To study the role of vitamin D in the prevention and treatment of cardio-renal syndrome (CRS), chronic allograft nephropathy (CAN), as well as in the renal and cardiac tissue reparation. Material and methods.
A. N. Kharlamov +4 more
doaj
Novel Biomarkers for the Assessment of the Cardio-Renal Syndrome-A Paradigm Shift. [PDF]
J Clin Med, 2023 Shacham Y.
europepmc +1 more source
How I treat thrombotic thrombocytopenic purpura and atypical haemolytic uraemic syndrome [PDF]
, 2014 Thrombotic thrombocytopenic purpura (TTP) and atypical haemolytic uraemic syndrome (aHUS) are acute, rare life-threatening thrombotic microangiopathies that require rapid diagnosis and treatment.
Goodship, T, Scully, M
core
The Evolution of Medications for Obesity Management
JGH Open, Volume 10, Issue 9, September 2026.ABSTRACT This narrative review provides an overview of progress in the development of obesity medications, including a synthesis of data describing the efficacy and safety of currently available agents and emerging therapeutic options. Historically, many obesity medications have been withdrawn from the market due to safety concerns.
Jaskirath Gill, Priya Sumithran
wiley +1 more source
Pathophysiology and diagnosis of cardio-renal syndrome: actual picture and future prospectives
, 2013 Pathophysiology and Diagnosis of Cardio-renal Syndrome: Actual Picture and Future Prospectives The cardio–renal syndrome (CRS) indicates how close the relationship is between heart and kidney during failure of these organs.
Gorini A +11 more
core